ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Genetics Research Is Prevalent In Central Europe as Scientists Seek Answers To Related Questions

August 16, 1991

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

Cancergrams Cost $840 Year For All

December 2, 1977

Sandra Swain Is Acting Chief Of NCI’s Medicine Branch.

July 21, 2000

Also MQSA should require mammography facilities to gather data on interpretation, cancer policy board committee says.

May 27, 2005

National Coalition Dinner Honors Cancer Program Founders, Advocates, And Cancer Survivors

March 6, 1992